Merck is in hot water after a class action lawsuit alleged securities fraud over its Gardasil revenue forecasts in China. The lawsuit claims Merck misled investors about its ability to achieve $11 ...

NEW YORK, NY / ACCESS Newswire / April 8, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

The Union Health Ministry plans to initiate capacity-building activities for frontline workers administering the HPV vaccine ...

Merck has a strong vaccine business, thanks to the human papillomavirus (HPV) products Gardasil and Gardasil 9. It's also a ...

Bernstein Liebhard LLP reminds Merck investors of an April 14, 2025 deadline to join a securities fraud class action lawsuit.

Despite this potential, the stock has fallen by 25% in the past 12 months -- so is it a bargain buy right now? During the ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

In its Q2 2024 earnings, MSD announced that sales for Gardasil were 17% lower (18% in exchange) compared to the previous year. At the time, the company attributed this to broader market headwinds ...

GSK’s restructuring of its distribution deal for its shingles vaccine Shingrix in December 2024, and MSD’s decision to pause sales of its blockbuster human papillomavirus (HPV) vaccine Gardasil until ...

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that Merck's ...

And so, we left the clinic without getting the HPV vaccine, also called Gardasil. Though over 10 years have passed since that appointment, for many Iowans, the conversation about the HPV vaccine ...

Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually prevents cancer. That’s because HPV is behind nearly all cervical cancer ...